Article metrics

Download PDFPDF
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

 

Online download statistics by month:

Online download statistics by month: March 2019 to October 2022

AbstractFullPdf
Mar 20192596194174
Apr 2019158117095
May 201965415079
Jun 20193867942
Jul 20192265525
Aug 20192745025
Sep 20192834022
Oct 20193353524
Nov 20193644323
Dec 20191953022
Jan 20202464024
Feb 20202964425
Mar 20203153727
Apr 20202643324
May 20202312621
Jun 20202203936
Jul 20201991310
Aug 20201602214
Sep 20202493425
Oct 20202974129
Nov 20202102620
Dec 20202463110
Jan 20213524228
Feb 20212804434
Mar 20212873322
Apr 20212634622
May 20211592916
Jun 2021373015
Jul 2021413417
Aug 2021342915
Sep 2021322511
Oct 20212553919
Nov 20213583323
Dec 20214224824
Jan 20224274825
Feb 20224747664
Mar 20225057749
Apr 20223944833
May 20223503213
Jun 20223833825
Jul 20223835224
Aug 20223823520
Sep 20223704522
Oct 20223897020
Total1640421851337